A Selective Culture Medium for Screening Cefiderocol Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii. 2023

Ahmad Ibrahim, and Maxime Bouvier, and Mustafa Sadek, and Jean-Winoc Decousser, and Laurent Poirel, and Patrice Nordmann
Clinical Microbiology Unit, Pasteur Institute of Lille, Lille, France.

Cefiderocol (FDC) is a siderophore cephalosporin with a broad spectrum of activity against many multidrug-resistant Gram-negative bacteria. Acquired resistance to FDC has been already reported among Gram-negative isolates, thus highlighting the need for rapid and accurate identification of such resistant pathogens, in order to control their spread. Therefore, the SuperFDC medium was developed to screen FDC-resistant Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii. After testing several culture conditions, a selective medium was set up by supplementing an iron-depleted agar medium with 8 μg/mL of FDC and evaluated with a collection of 68 FDC-susceptible and 33 FDC-resistant Gram-negative isolates exhibiting a variety of β-lactam resistance mechanisms. The sensitivity and specificity of detection of this medium were evaluated at 97% and 100%, respectively. In comparison with the reference broth microdilution method, only 3% very major errors were found. In addition, excellent detection performances were obtained by testing spiked stools with a lower limit of detection ranging between 100 and 103 CFU/mL. The SuperFDC medium allows detection of FDC-resistant Gram-negative isolates regardless of their corresponding resistance mechanisms.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097602 Cefiderocol A siderophore cephalosporin with enhanced activity against GRAM-NEGATIVE AEROBIC BACTERIA. Cefiderocol Sulfate Tosylate,Fetroja,S-649266,S 649266,S649266
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D024901 Drug Resistance, Multiple, Bacterial The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Drug Resistance, Extensive, Bacterial,Drug Resistance, Extensively, Bacterial,Extensive Antibacterial Drug Resistance,Extensively Antibacterial Drug Resistance,Multidrug Resistance, Bacterial,Multiple Antibacterial Drug Resistance,Bacterial Multidrug Resistance,Bacterial Multidrug Resistances,Resistance, Bacterial Multidrug
D040981 Acinetobacter baumannii A species of gram-negative, aerobic bacteria, commonly found in the clinical laboratory, and frequently resistant to common antibiotics. Bacterium anitratum

Related Publications

Ahmad Ibrahim, and Maxime Bouvier, and Mustafa Sadek, and Jean-Winoc Decousser, and Laurent Poirel, and Patrice Nordmann
August 2020, Journal of clinical microbiology,
Ahmad Ibrahim, and Maxime Bouvier, and Mustafa Sadek, and Jean-Winoc Decousser, and Laurent Poirel, and Patrice Nordmann
November 2020, Journal of clinical microbiology,
Ahmad Ibrahim, and Maxime Bouvier, and Mustafa Sadek, and Jean-Winoc Decousser, and Laurent Poirel, and Patrice Nordmann
July 2020, Microbial drug resistance (Larchmont, N.Y.),
Ahmad Ibrahim, and Maxime Bouvier, and Mustafa Sadek, and Jean-Winoc Decousser, and Laurent Poirel, and Patrice Nordmann
January 2022, Journal of clinical microbiology,
Ahmad Ibrahim, and Maxime Bouvier, and Mustafa Sadek, and Jean-Winoc Decousser, and Laurent Poirel, and Patrice Nordmann
July 2020, The Journal of antimicrobial chemotherapy,
Ahmad Ibrahim, and Maxime Bouvier, and Mustafa Sadek, and Jean-Winoc Decousser, and Laurent Poirel, and Patrice Nordmann
February 2024, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Ahmad Ibrahim, and Maxime Bouvier, and Mustafa Sadek, and Jean-Winoc Decousser, and Laurent Poirel, and Patrice Nordmann
February 2015, Deutsche medizinische Wochenschrift (1946),
Ahmad Ibrahim, and Maxime Bouvier, and Mustafa Sadek, and Jean-Winoc Decousser, and Laurent Poirel, and Patrice Nordmann
October 2021, Microbial drug resistance (Larchmont, N.Y.),
Ahmad Ibrahim, and Maxime Bouvier, and Mustafa Sadek, and Jean-Winoc Decousser, and Laurent Poirel, and Patrice Nordmann
January 1990, Acta veterinaria Hungarica,
Ahmad Ibrahim, and Maxime Bouvier, and Mustafa Sadek, and Jean-Winoc Decousser, and Laurent Poirel, and Patrice Nordmann
September 2022, Journal of laboratory physicians,
Copied contents to your clipboard!